VarCov Co’s Madison Square Garden MSGS Stock Holding History

VarCov Co’s Portfolio MSGS Stock Details MSGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,938	Closed	-$760K	–	538
2025 Q4	$760K	Buy	+2,938	New	+$669K	0.3%	97

Other funds holding MSGS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VarCov Co's MSGS Position: Q1 2026 in Review

VarCov Co sold out of Madison Square Garden (MSGS) in Q1 2026, closing a stake of 2,938 shares — an estimated $760K sold.

VarCov Co first reported a position in MSGS in Q4 2025 and held it in 1 quarter. The position peaked at $760K in Q4 2025. 410 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

VarCov Co reported no remaining Madison Square Garden position as of Q1 2026 after selling out during the quarter.
VarCov Co sold 2,938 Madison Square Garden shares in Q1 2026, an estimated $760K.
VarCov Co first reported a position in Madison Square Garden in Q4 2025 and held it in 1 quarter.
VarCov Co's Madison Square Garden position peaked at $760K in Q4 2025.
410 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.